HK1206594A1 - 預防和治療病毒感染的材料和方法 - Google Patents

預防和治療病毒感染的材料和方法

Info

Publication number
HK1206594A1
HK1206594A1 HK15107041.7A HK15107041A HK1206594A1 HK 1206594 A1 HK1206594 A1 HK 1206594A1 HK 15107041 A HK15107041 A HK 15107041A HK 1206594 A1 HK1206594 A1 HK 1206594A1
Authority
HK
Hong Kong
Prior art keywords
prevention
treatment
materials
methods
viral infections
Prior art date
Application number
HK15107041.7A
Other languages
English (en)
Inventor
．劉
．楊
Original Assignee
Bagi Res Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bagi Res Ltd filed Critical Bagi Res Ltd
Publication of HK1206594A1 publication Critical patent/HK1206594A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/18—Acyclic radicals, substituted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7012—Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
HK15107041.7A 2012-04-20 2015-07-23 預防和治療病毒感染的材料和方法 HK1206594A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261636184P 2012-04-20 2012-04-20
PCT/IB2013/001074 WO2013156858A1 (en) 2012-04-20 2013-04-16 Materials and methods for prevention and treatment of viral infections

Publications (1)

Publication Number Publication Date
HK1206594A1 true HK1206594A1 (zh) 2016-02-05

Family

ID=49380661

Family Applications (2)

Application Number Title Priority Date Filing Date
HK15105629.1A HK1205676A1 (zh) 2012-04-20 2015-06-15 預防和治療病毒感染的材料與方法
HK15107041.7A HK1206594A1 (zh) 2012-04-20 2015-07-23 預防和治療病毒感染的材料和方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HK15105629.1A HK1205676A1 (zh) 2012-04-20 2015-06-15 預防和治療病毒感染的材料與方法

Country Status (10)

Country Link
US (1) US9156871B2 (zh)
EP (1) EP2838526A4 (zh)
JP (1) JP6195902B2 (zh)
KR (1) KR20150030643A (zh)
CN (1) CN104244943A (zh)
AU (1) AU2013250891B2 (zh)
CA (1) CA2867257A1 (zh)
HK (2) HK1205676A1 (zh)
TW (1) TW201345903A (zh)
WO (1) WO2013156858A1 (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2890981T3 (en) * 2012-08-28 2019-03-04 Univ Tuebingen Medizinische Fakultaet Senescence tracers
CN114507264A (zh) * 2022-01-06 2022-05-17 湖南中医药大学 金丝皇菊的提取单体皇菊素a及其提取方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2912843B2 (ja) * 1995-03-17 1999-06-28 東洋水産株式会社 アルキルβ−ルチノシドの製造方法および新規アルキルβ−ルチノシド
CN1194982C (zh) 2002-12-11 2005-03-30 中国科学院南海海洋研究所 一种苯乙醇苷化合物－老鼠簕苷a的结构及其用途
JP2005162756A (ja) * 2003-11-05 2005-06-23 Katsutoshi Terasawa β−グルクロニダーゼ阻害剤
EP1736167B1 (en) * 2005-06-20 2018-03-21 I.R.B. Istituto Di Ricerche Biotecnologiche S.r.l. Extracts obtained from cell line cultures from Syringa vulgaris IRB-SV25/B (DMS:16857), their preparation and use
EP1736166B2 (en) 2005-06-20 2018-02-28 I.R.B. Istituto Di Ricerche Biotecnologiche S.r.l. Extracts from Ajuga reptans cell lines, their preparation and use
EP2041152A1 (fr) * 2006-06-23 2009-04-01 RDW Pharma Compose d-glucopyranose 1-[3,5-bis(1,1-dimethylethyl)-4- hydroxybenzoate] et ses derives, leur preparation et leurs utilisations
US20080261896A1 (en) * 2007-04-11 2008-10-23 Sinphar Pharmaceutical Co., Ltd. Testosterone generating and metabolizing enhancer
CN101519457B (zh) * 2009-03-17 2011-04-13 徐德平 一种β-乙氧基芸香糖的制备方法及其降低血糖的应用
EP2521554B1 (en) * 2009-12-30 2017-11-22 BAGI Research Limited Materials and methods for prevention and treatment of viral infections
CN101897715B (zh) * 2010-08-16 2012-07-11 江西山香药业有限公司 女贞苷、野漆树苷组合物及其制备药物用途
CN102304156B (zh) 2011-06-24 2016-03-16 浙江爱诺药业股份有限公司 一种苯乙醇苷类成份及其制备方法和用途

Also Published As

Publication number Publication date
CA2867257A1 (en) 2013-10-24
AU2013250891B2 (en) 2017-11-02
KR20150030643A (ko) 2015-03-20
JP2015514744A (ja) 2015-05-21
US20130281393A1 (en) 2013-10-24
CN104244943A (zh) 2014-12-24
EP2838526A4 (en) 2016-03-30
JP6195902B2 (ja) 2017-09-13
HK1205676A1 (zh) 2015-12-24
TW201345903A (zh) 2013-11-16
WO2013156858A1 (en) 2013-10-24
US9156871B2 (en) 2015-10-13
EP2838526A1 (en) 2015-02-25
AU2013250891A1 (en) 2014-10-02

Similar Documents

Publication Publication Date Title
ZA201500921B (en) Alkylpyrimidine derivatives for the treatment of viral infections and further diaseases
HK1203944A1 (zh) 用於治療和預防乙型肝炎病毒感染的 -甲基-二氫嘧啶類
HK1211589A1 (zh) 用於治療副粘病毒病毒性感染的化合物
ZA201405820B (en) Piperidino-pyrimidine derivatives for the treatment of viral infections
HK1222398A1 (zh) 治療伯克霍爾德氏菌感染症的組合物及方法
HK1210463A1 (zh) 用於治療病毒感染和另外的疾病的酰氨基嘧啶衍生物
HK1210022A1 (zh) 治療乙型肝炎及丁型肝炎感染的方法
HK1200348A1 (zh) 用於治療龐貝氏症的方法和材料
GB201217296D0 (en) Method of treatment and/or prevention
EP2928470A4 (en) THIENOPYRIDINE DERIVATIVES FOR THE TREATMENT AND PREVENTION OF DENGUE VIRUS INFECTIONS
EP2802353A4 (en) COMPOSITIONS AND METHOD FOR THE TREATMENT OF VIRUS INFECTIONS
EP2869821A4 (en) COMPOSITIONS AND METHODS FOR TREATING AND INHIBITING VIRAL INFECTIONS
AP2015008338A0 (en) Compounds for the treatment and prevention of retroviral infections
EP2663327A4 (en) COMPOSITIONS AND METHOD FOR THE TREATMENT OF VIRUS INFECTIONS
HK1201181A1 (zh) 用於治療和預防病毒感染的新型環孢菌素衍生物
ZA201501601B (en) Virus purification and formulation process
HK1206594A1 (zh) 預防和治療病毒感染的材料和方法
ZA201306342B (en) The treatment of viral infections
PL2838903T3 (pl) Sposoby i kompozycje do leczenia zakażeń wirusowych
HK1205680A1 (zh) 用於治療丙型肝炎病毒的藥劑
ZA201407163B (en) Triazines with suitable spacers for treatment and/or prevention of hiv infections
ZA201407866B (en) Composition for the prevention and treatment of viral infections caused by retroviruses
AU2011902348A0 (en) Novel treatment and prevention of dog viral infections
GB201012168D0 (en) Treatment of viral infections
GB201001821D0 (en) Treatment of viral infections